Clinical and genetic characterization of Italian patients affected by CINCA syndrome

Rheumatology

Volumn 46, Issue 3, 2007, Pages 473-478

  Caroli, F ^a   Pontillo, A ^b   D'Osualdo, A ^a   Travan, L ^b   Ceccherini, I ^a   Crovella, S ^b   Alessio, M ^c   Stabile, A ^d   Gattorno, M ^e   Tommasini, A ^b   Martini, A ^e   Lepore, L ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Anakinra; ASC; CIAS1; Congenital autoinflammatory disease

Indexed keywords

CRYOPYRIN; GENE PRODUCT; GENOMIC DNA; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOTIDE BINDING PROTEIN; PROTEIN CIAS1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; CINCA SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC TRAIT; HETEROZYGOSITY; HUMAN; ITALY; MALE; MENTAL DEFICIENCY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; REGISTER; SYMPTOM;

ADOLESCENT; ADULT; ARTHRITIS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MUTATION, MISSENSE; REGISTRIES; SYNDROME; TREATMENT OUTCOME; URTICARIA;

EID: 33847379803     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel269     Document Type: Article

References (35)

1. Aksentijevich I, Nowak M, Mallah M et al. De Novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID). Arthritis rheum 2002;46:3340-48.
2. Feldmann J, Prieur AM, Quartier P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
3. Aganna E, Martinon F, Hawkins PN et al. McDermott association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46:2445-52.
4. Neven B, Callebaut I, Prieur AM et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated auto-inflammatory disorders (CINCA/NOMID, MWS, FCU). Blood 2004;103:2809-15.
5. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-5.
6. Hoffman HM, Gregory SG, Mueller JL et al. Fine structure mapping of CIAS1: Identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet 2003;112:209-16.
7. Rosen-Wolff A, Quietzsch J, Schroder H, Lehmann R, Gahr M, Roesler J. Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment. Eur J Haematol 2003;71:215-9.
8. Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ. Neonatal-onset multisystem inflammatory disorder: The emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol 2005;141:248-53.
9. Ting JP, Davis BK. CATERPILLER: A novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2005;23:387-414.
10. Harton AA, Linhoff MW, Zhang J, Ting JP. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 2002;169:4088-93.
11. Koonin EV, Aravind L. The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem Sci 2000;25:223-4.
12. Masumoto J, Dowds TA, Schaner P et al. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 2003;303:69-73.
13. O'Connor W, Harton JA, Zhu X, Linhoff MW, Ting JP-Y. Cutting edge: CIAS1/ Cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-κB suppressive properties. J Immunol 2003;171.
14. Gumucio DL, Diaz A, Schaner P et al. Fire and ICE: The role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002;20:S45-53.
15. Manji GA, Wang L, Geddes BJ et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 2002;277:11570-5.
16. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002;277:21119-22.
17. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002;3:221-7.
18. Martinon F, Burns K, Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-26.
19. Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: Enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 2004;279:21924-8.
20. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004;20:319-25.
21. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in MWS and response to anakinra. Arthritis Rheum 2004;50:607-12.
22. Hawkins PN, Bybee A, Aganna E, McDermott MF. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis Rheum 2004;50:2708-9.
23. Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in FCAS by IL-1 receptor antagonist. Lancet 2004;364:1779-85.
24. Frenkel J, Wulffraat NM, Kuis W. Anakinra in mutation-negative NOMID/ CINCA syndrome: Comment on the articles by Hawkins et al. and Hoffman and Patel. Arthritis Rheum 2004;50:3738-9; author reply 3739-40.
25. Ramos E, Arostegui JI, Campuzano S, Rius J, Bousono C, Yague J. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). J Rheumatology 2005;44:1072-3.
26. Lovell DJ, Bowyer SL, Solinger AM. IL-1 blockade by anakinra improves clinical symptoms in patients with NOMID. Arthritis Rheum 2005;52:1283-6.
27. De Cunto CL, Liberatore DI, San Roman JL, Goldberg JC, Morandi AA, Feldman G. Infantile-onset multisystem inflammatory disease: A differential diagnosis of systemic juvenile rheumatoid arthritis. J Pediatr 1997;130:551-6.
28. Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol 132:98-108.
29. Takada H, Kusuhara K, Nomura A et al. A novel CIAS1mutation in a Japanese patient with chronic infantile neurological cutaneous and articular syndrome. Eur J Pediatr 2005;164:785-6.
30. Dode C, Le Du N, Cuisset L et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: A novel mutation underlies both syndromes. Am J Hum Genet 2002;70:1498-506.
31. Anderson JP, Mueller JL, Rosengren S et al. Structural, expression, and evolutionary analysis of mouse CIAS1. Gene 2004;338:25-34.
32. Prieur AM, Lovell D. The chronic, infantile, neurological, cutaneous and articular syndrome. In: Woo, White, Ansell, eds. Pediatric Rheumatology Update. Oxford: Oxford University Press, 1990;146-59.
33. Russo RA, Katsicas MM. Chronic infantile neurological cutaneous and articular syndrome: Two new cases with rare manifestations. Acta Paediatr 2001;90:1076-9.
34. Arostegui JI, Aldea A, Modesto C et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004;50:4045-50.
35. Levine A, Dalal I, Bujanover Y. Celiac disease associated with familial chronic urticaria and thyroid autoimmunity in a child. Pediatrics 1999;104:e25.